BNP Paribas Financial Markets’s PolyPid PYPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.2K Sell
9,177
-103
-1% -$456 ﹤0.01% 4811
2025
Q4
$40.3K Sell
9,280
-454
-5% -$1.69K ﹤0.01% 4783
2025
Q3
$32.5K Buy
9,734
+3,500
+56% +$12.1K ﹤0.01% 4774
2025
Q2
$22K Buy
6,234
+5,400
+647% +$15.8K ﹤0.01% 4563
2025
Q1
$2.26K Hold
834
﹤0.01% 4969
2024
Q4
$2.63K Buy
+834
New +$2.74K ﹤0.01% 4985

Other funds holding PYPD

BNP Paribas Financial Markets's PYPD Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its PolyPid (PYPD) stake by 1.1% in Q1 2026, selling an estimated $456 and leaving 9,177 shares worth $40.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4811.

BNP Paribas Financial Markets first reported a position in PYPD in Q4 2024 and has held it in 6 quarters since. The position peaked at $40.3K in Q4 2025. 19 funds tracked by Wall St. Rank hold PYPD as of Q1 2026.

  • BNP Paribas Financial Markets held 9,177 shares of PolyPid worth $40.2K as of Q1 2026.
  • BNP Paribas Financial Markets sold 103 PolyPid shares in Q1 2026, an estimated $456.
  • PolyPid made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4811 holding.
  • BNP Paribas Financial Markets first reported a position in PolyPid in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's PolyPid position peaked at $40.3K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held PolyPid as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.